ReviewCurrent psychiatry reports2025
Supporting Clinicians in Implementing Exposure Therapy for Anxiety and Related Disorders.
Review in Current psychiatry reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bridging Intervention and Implementation Research for More Personalized Behavioral Health.Clinical psychology : a publication of the Division of Clinical Psychology of the American Psychological Association · 2026Article
- Fear of Fear: Challenges and Negative Beliefs About Gradual Exposure Use in TF-CBT.Evidence-based practice in child and adolescent mental health · 2026Article
- Exposure-based Interventions for Chronic Pain and Bodily Symptoms: A Special Interest Meeting Report.Behaviour research and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewExposure therapy is the gold standard treatment for anxiety and related disorders. Despite its strong evidence, it is rarely delivered in routine clinical settings. A growing body of literature has identified factors that impede delivery of exposure therapy and strategies that can increase its use. This review of research from the past 5 years: (1) summarizes barriers to delivering exposure; (2) identifies evidence-based strategies to support clinicians in increasing their delivery of exposure; and (3) highlights emerging trends and challenges in supporting clinicians to use exposure. RECENT
findingsBarriers to delivering exposure occur at the clinician, client, and organizational levels. Clinician training and organizational policies need to directly address multi-level barriers to support clinicians in using exposure. Technology-related considerations (e.g., virtual reality, telehealth) should be considered and clinicians should receive support from others (e.g., bachelor's-level providers; family peer navigators) to address increasing rates of anxiety disorders.
Indexed as
Identifiers
40307506What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.